Treatment of the Biceps With Concomitant Supraspinatus Tears

March 20, 2024 updated by: Dr. Alexandre Lädermann, La Tour Hospital

Treatment of the Biceps With Concomitant Supraspinatus Tears: A Multicenter Pragmatic Three-Arm Parallel-Group Randomized Surgical Trial

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology.Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact. The primary goal of this prospective multicenter randomized study is to evaluate whether LHB tenodesis grants superior post-operative functional outcomes compared to LHB tenotomy or leaving the LHB intact in patients undergoing rotator cuff repair (RCR) for an isolated full-thickness lesion of the supraspinatus. The primary goal of this prospective multicenter randomized study is to evaluate whether LHB tenodesis grants superior post-operative functional outcomes compared to LHB tenotomy or leaving the LHB intact in patients undergoing rotator cuff repair (RCR) for an isolated full-thickness lesion of the supraspinatus. The secondary goals are to determine whether there is a difference in post-operative functional outcomes between the LHB tenotomy group and the Intact LHB group, and if there is a difference in complication rates or patient satisfaction between the three groups.

Study Type

Interventional

Enrollment (Estimated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T3B 6B7
    • Geneva
      • Meyrin, Geneva, Switzerland, 1217
    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Recruiting
        • Sports Medicine and Shoulder Surgery, University of Michigan
        • Contact:
    • Oregon
      • Portland, Oregon, United States, 97239
        • Recruiting
        • Oregon Health & Science University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.
  • Full thickness tear of the supraspinatus tendon
  • Intact subscapularis tendon
  • Primary rotator cuff repair
  • Age 50-80

Exclusion Criteria:

  • Previous full thickness biceps tear
  • Infection and neuropathic joints
  • Known or suspected non-compliance, drug or alcohol abuse
  • Patients incapable of judgement or under tutelage
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for MRI scan etc.
  • Enrolment of the investigator, his/her family members, employees and other dependent persons
  • Patient declines to participate in study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Leaving LHB Intact
The long head of the biceps (LHB) will be left intact.
Experimental: LHB tenotomy
The long head of the biceps (LHB) will be cut at its origin.
Will be performed arthroscopically by cutting the LHB at its origin with arthroscopic scissors
Experimental: LHB Tenodesis
The long head of the biceps (LHB) will be cut at its origin and reattached.
"ill be performed arthroscopically with a tenodesis at the top of the articular margin using an onlay technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ASES score
Time Frame: At 24 post-operative months
American Shoulder and Elbow Surgeon (ASES) score. From 0 (worst) to 100 (best).
At 24 post-operative months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS pain
Time Frame: At 24 post-operative months
Visual analog scale (VAS) pain. From 0 (best) to 10 (worst)
At 24 post-operative months
SSV
Time Frame: At 24 post-operative months
Subjective Shoulder Value (SSV). From 0 (worst) to 100 (best).
At 24 post-operative months
LHB score
Time Frame: At 24 post-operative months
Long head of the biceps (LHB) score. From 0 (worst) to 100 (best).
At 24 post-operative months
AFF
Time Frame: At 24 post-operative months
Anterior Forward Flexion. In degrees. Will be performed with a goniometer by an independent investigator
At 24 post-operative months
ER at side
Time Frame: At 24 post-operative months
External Rotation at the side. In degrees. Will be performed with a goniometer by an independent investigator
At 24 post-operative months
IR
Time Frame: At 24 post-operative months
Internal Rotation to nearest spinal level. Will be performed with a goniometer by an independent investigator
At 24 post-operative months
Complications
Time Frame: Within 2 postoperative years
Any type of post-operative complication
Within 2 postoperative years
Patient satisfaction
Time Frame: At 24 post-operative months
Yes or no
At 24 post-operative months
Location of the defect (at the foot print | medial cuff failure)
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Status of the biceps tendon (intact | in continuity | defect)
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Signs of anchor displacement and location (lateral | medial row).
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Tendon thickness
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Number of patients with bursitis
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Number of patients with healing of the Supraspinatus tear according to Sugaya classification
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Number of patients with liquid in the bicipital sheath
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month
Number of patients with hypervascularization of the sheath
Time Frame: At 6 post-operative month
Radiographic outcome evaluated using an ultrasound examination.
At 6 post-operative month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexandre Lädermann, MD, La Tour Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

December 4, 2022

First Submitted That Met QC Criteria

December 13, 2022

First Posted (Actual)

December 21, 2022

Study Record Updates

Last Update Posted (Actual)

March 21, 2024

Last Update Submitted That Met QC Criteria

March 20, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supraspinatus Tear

Clinical Trials on LHB Tenotomy

3
Subscribe